SCHEMBL5519299

SCHEMBL5519299

Fc1ccc(COCC2CCC3(CC2)OCCO3)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1809933 0.85 CTSL (0.45)
SCHEMBL5525454 0.84 IDO1 (0.41)
SCHEMBL5848185 0.80 TRPA1 (0.42)
SCHEMBL14451415 0.80 TRPA1 (0.44)
SCHEMBL5524579 0.79 GPR119 (0.44)
SCHEMBL5514770 0.79 CARM1 (0.46)
Hydrochloric Acid SCHEMBL5515267 0.79 TRPA1 (0.43)
Hydrochloric Acid SCHEMBL5515266 0.79 TRPA1 (0.43)
Hydrochloric Acid SCHEMBL5515265 0.79 TRPA1 (0.43)
SCHEMBL5522560 0.78 L3MBTL1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167452-A1 Therapeutic amide derivatives PFIZER, INC. 2007-07-19 US disclosed
US-20070167452-A1 Therapeutic amide derivatives PFIZER, INC. 2007-07-19 US disclosed
US-20070167452-A1 Therapeutic amide derivatives PFIZER, INC. 2007-07-19 US disclosed
EP-1716100-A2 THERAPEUTIC AMIDE DERIVATIVES Pfizer, Inc. (US) 2006-11-02 EP disclosed
WO-2005080317-A2 THERAPEUTIC AMIDE DERIVATIVES PFIZER JAPAN, INC. (JP) 2005-09-01 WO disclosed
WO-2005080317-A2 THERAPEUTIC AMIDE DERIVATIVES PFIZER JAPAN, INC. (JP) 2005-09-01 WO disclosed